DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 089645
NDA 089645 describes LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, which is a drug marketed by Belmora Llc, Eastman Kodak, Hospira, West-ward Pharms Int, and Empi, and is included in thirteen NDAs. It is available from six suppliers. Additional details are available on the LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE profile page.
The generic ingredient in LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
The generic ingredient in LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 089645
| Tradename: | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
| Applicant: | Hospira |
| Ingredient: | epinephrine; lidocaine hydrochloride |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 089645
| Ingredient-type | Amides Catecholamines |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 089645
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | epinephrine; lidocaine hydrochloride | INJECTABLE;INJECTION | 089645 | ANDA | Hospira, Inc. | 0409-3181 | N | 0409-3181-01 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.005MG/ML;1.5% | ||||
| Approval Date: | Jun 21, 1988 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
